These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38744243)

  • 1. Totally Implantable Venous Access Device Care Practices and Experiences of Pediatric and Adult Oncology Nurses.
    Gündogdu F; Semerci R; Bay F
    J Infus Nurs; 2024 May-Jun 01; 47(3):182-189. PubMed ID: 38744243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
    Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
    Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese expert consensus on the nursing management of the totally implantable venous access device.
    Xu Y; Fei XY; Xue YH; Wang XM; Wang XY; Zheng YT; Chen K; He JJ; Ren XH; Pan L; Wang L; Qian D; Li WF; Liang Y; Fang Y; Huang XF; Li CH; Chen DP; Wang Y; Wen LH; Zhang YH; Zheng Y; Song H; Lin YC; Zhang Q; Yang RM; Wang ZM
    J Cancer Res Ther; 2022 Sep; 18(5):1231-1240. PubMed ID: 36204867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
    Kim JT; Oh TY; Chang WH; Jeong YK
    Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point prevalence study of cancer nursing practices for managing intravascular devices in an Australian tertiary cancer center.
    Russell E; Chan RJ; Marsh N; New K
    Eur J Oncol Nurs; 2014 Jun; 18(3):231-5. PubMed ID: 24373944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-based prediction of cephalic vein cutdown success prior to totally implantable venous access device placement.
    Staszewicz W; Naiken SP; Mennet A; Meyer J; Righini M; Morel P; Toso C
    J Vasc Surg Venous Lymphat Disord; 2019 Nov; 7(6):865-869.e1. PubMed ID: 31495770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications related to totally implantable venous access devices in children and adults following lung transplantation.
    Cho JK; Acord M; Goldfarb SB; Reddy SN; Goldberg HJ; Courtwright AM
    Clin Transplant; 2019 Feb; 33(2):e13465. PubMed ID: 30561770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
    Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
    World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
    Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
    Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of flushing with aseptic non-touch technique using pre-filled flush or manually prepared syringes on central venous catheter occlusion and bloodstream infections in pediatric hemato-oncology patients: A randomized controlled study.
    Gerçeker GÖ; Sevgili SA; Yardımcı F
    Eur J Oncol Nurs; 2018 Apr; 33():78-84. PubMed ID: 29551181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Risk Factors for Totally Implantable Venous Access Device Infections in Pediatric Patients With Cancer: A Study of 25,954 Device-Days.
    Lee JK; Choi YB
    J Korean Med Sci; 2022 Sep; 37(35):e266. PubMed ID: 36065650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A totally implantable venous access device (TIVAD) abandoned for 5 years is re-accessed normally: A case report and literature review.
    He J
    J Vasc Access; 2023 May; 24(3):502-506. PubMed ID: 34396820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
    Covey AM; Toro-Pape FW; Thornton RH; Son C; Erinjeri J; Sofocleous CT; Brody LA; Brown KT; Sepkowitz KA; Getrajdman GI
    J Vasc Interv Radiol; 2012 Mar; 23(3):358-62. PubMed ID: 22365295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Totally implantable venous access device in children with cancer lead to disfiguring scar.
    Braam KI; Veening MA; Schouten-van Meeteren AY; van Dulmen-den Broeder E; Heij HA
    Pediatr Hematol Oncol; 2013 Mar; 30(2):154-64. PubMed ID: 23302017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine chest X-ray is not mandatory after fluoroscopy-guided totally implantable venous access device insertion.
    Thomopoulos T; Meyer J; Staszewicz W; Bagetakos I; Scheffler M; Lomessy A; Toso C; Becker CD; Morel P
    Ann Vasc Surg; 2014 Feb; 28(2):345-50. PubMed ID: 24360633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the interval of flushing procedures of totally implantable vascular access devices in cancer patients: It is time for a change.
    Bertoglio S
    J Vasc Access; 2021 Sep; 22(5):689-691. PubMed ID: 32962527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.